Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine

PHASE2CompletedINTERVENTIONAL
Enrollment

313

Participants

Timeline

Start Date

March 30, 2018

Primary Completion Date

June 17, 2019

Study Completion Date

July 16, 2019

Conditions
Migraine
Interventions
BIOLOGICAL

B244

B244 Suspension

BIOLOGICAL

Vehicle

Vehicle Suspension

Trial Locations (22)

14609

Rochester Clinical Research INC, Rochester

22911

Charlottesville Medical Research, Charlottesville

28401

PMG Research of Wilmington, Wilmington

29406

Coastal Carolina Research Center, North Charleston

30033

Neurostudies Clinical Research, Decatur

32256

Clinical Neuroscience Solution, Inc, Jacksonville

32801

Clinical Neuroscience Solution, Inc, Orlando

33319

Precision Clinical Research, Lauderdale Lakes

33409

Palm Beach Research, West Palm Beach

38119

Clinical Neuroscience Solution, Inc, Memphis

45212

CTI Clinical Research Center, Cincinnati

72205

Baptist Health Center for Clinical Research, Little Rock

75231

FutureSearch Trials of Dallas, L.P., Dallas

77081

Texas Center for Drug Development, Houston

78731

FutureSearch Trials of Neurology and Sleep Lab, L.P., Austin

89102

Altea Research Institute, Las Vegas

90404

Neurological Research Institute, Santa Monica

90806

Collaborative Neuroscience Network, LLC, Long Beach

92506

CI Trials, Riverside

06905

New England Institute for Neurology and Headache (NEINH)/Medical Practice, Stamford

02740

BTC of New Bedford, New Bedford

02472

MedVadis Research, Watertown

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Veristat, Inc.

OTHER

lead

AOBiome LLC

INDUSTRY